TrialCancer2016

Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E1508).

Chandra P Belani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.